Financial News
Articles published by Aditxt, Inc.
Aditxt, Inc. (Nasdaq: ADTX) Announces 1-for-50 Reverse Stock Split Effective Pre-Market Opening on September 14, 2022
September 13, 2022
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Aditxt to Participate in the 2022 Virtual Growth Conference
March 23, 2022
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Aditxt Provides Online Business Update Townhall Meeting with Amro Albanna, Co-Founder & CEO
January 12, 2022
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Aditxt Signs Amendment to Extend Worldwide Licensing Agreement, Granting Exclusivity in all Fields of Use
December 29, 2021
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Aditxt, Inc. Signs Non-Binding Letter of Intent to Acquire Point-of-Care Diagnostic Technology Development Company
December 13, 2021
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Aditxt Announces Closing of $17.4 Million Firm Commitment Public Offering of Common Stock and Warrants
December 06, 2021
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Aditxt Extends the Timeline to Sign the Definitive Agreement to Acquire AiPharma Global to December 16, 2021
December 02, 2021
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Aditxt Announces Proposed Public Offering of Common Stock and Warrants
November 30, 2021
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Aditxt Webinar at 2pm ET to Explore PRESECO Results
November 12, 2021
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Aditxt Provides an Update Regarding its Target Acquisition AiPharma Global Holdings LLC
November 12, 2021
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Aditxt Announces Closing of $4.25 Million Public Offering
October 20, 2021
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Aditxt to Present at the Dawson James 6th Annual Small Cap Growth Conference in Florida on October 21, 2021
October 20, 2021
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Aditxt Announces Pricing of $4.25 Million Public Offering
October 18, 2021
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Aditxt Announces Pricing of $11.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
August 26, 2021
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Aditxt Provides Update on AditxtReprogramming’s™ Apoptotic DNA Immunotherapy Therapeutic Platform
August 04, 2021
From Aditxt, Inc.
Via Business Wire
Tickers
ADTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.